| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P10321 and P01732 |
Pubmed |
SVM Score :0.0 |
| Thalidomide did not modify : ( a ) adhesion and / or signal transducing molecules such as CD 2 , CD 4 , CD 5 and CD 8 , or ( b ) molecules that facilitate antigen presentation such as HLA DR , HLA A , HLA B , or HLA C . . ^^^ |
|